Fortress Biotech, Inc. (NASDAQ: FBIO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Fortress Biotech, Inc. (NASDAQ: FBIO) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $10.00 price target on the stock.
Fortress Biotech to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase [Yahoo! Finance]
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]